Altria Group, Inc. MO is keeping the cigarette strategy centered on the premium segment, which accounts for about 85% of profitability in the cigarette category. That makes Marlboro’s position especially important as cigarette consumers continue to trade down toward discount offerings amid pressure on discretionary income.
In the second quarter of 2026, Marlboro held a 59.6% share of the premium segment, unchanged from a year earlier and up 0.1 percentage point sequentially. However, Marlboro’s share of the total cigarette category fell 1.5 percentage points year over year to 39.5%. At the same time, industry discount retail share rose 2.6 percentage points to 33.8%, reflecting continued trade-down among adult nicotine consumers.
Altria is addressing the shift toward discount cigarettes through a broader PM USA portfolio strategy. Basic’s retail share increased 2.3 percentage points year over year to 2.9% in the second quarter, while targeted promotional support expanded to roughly 35,000 stores during the first half of 2026. The strategy seeks to participate in the discount segment while limiting the impact on Marlboro.
Despite the mix shift, smokeable price realization was 4.5% in the quarter, supported by strong Marlboro net pricing. Smokeable products adjusted OCI increased 2.4% to $3.02 billion, while adjusted OCI margin expanded 0.3 percentage point to 64.8%. The premium segment therefore remains central to cigarette profitability even as discount participation grows.
How Altria Compares With Philip Morris and TPB
Philip Morris International Inc. PM also showed premium-brand resilience in second-quarter 2026. While international combustible pricing rose 10%, Philip Morris’ Marlboro share reached a record 11% of the international cigarette category, up 0.3 percentage points year over year. Philip Morris also maintained a 25.3% cigarette category share, with international combustible gross profit increasing 8% organically in the quarter despite unfavorable geographic mix.
Turning Point Brands, Inc. TPB is also leaning on premium positioning across nicotine products. While Modern Oral investments focus on shelf placement, retail visibility and brand equity to build long-term premium potential, Turning Point Brands described Stoker’s as the segment’s only truly premium product for value-oriented consumers. Turning Point Brands reported Stoker’s segment net sales up 54.5%, with adjusted gross profit rising 40.7% year over year.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have fallen 3.4% in the past three months against the industry’s growth of 2.7%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 11.90X, down from the industry’s average of 14.92X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2026 and 2027 earnings implies year-over-year growth of 4.6% and 3%, respectively.
Altria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Altria Group, Inc. (MO): Free Stock Analysis Report
Philip Morris International Inc. (PM): Free Stock Analysis Report
Turning Point Brands, Inc. (TPB): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).